Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kerrigan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Role of computational methods in pharmaceutical sciencesSandhya Kortagere, Markus Lill, John Kerrigan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
The distribution of the cost of multiple sclerosis in the UK: how do costs vary by illness severity?David Tyas, John Kerrigan, Nicola Russell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2007
The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UKMichelle Orme, John Kerrigan, David Tyas, et al.
Oncotarget|February 6, 2016
MTHFD2--a new twist?Philip M Tedeschi, Kathleen W Scotto, John Kerrigan, et al.
Pharmacoeconomics|June 20, 2008
Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UKRay Gani, Gavin Giovannoni, David Bates, et al.
Biochemistry|December 5, 2008
Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activityHye-Jin Park, Haiyan Zheng, Diptee Kulkarni, et al.
The Journal of Biological Chemistry|August 11, 2011
Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIαRen-Kuo Lin, Nai Zhou, Yi Lisa Lyu, et al.
BMC Cancer|July 18, 2015
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomasSunniva Stordal Bjørklund, Vessela N Kristensen, Michael Seiler, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analoguesLata T Gooljarsingh, Christine Fernandes, Kang Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate CancerNitu Bansal, Monica Bartucci, Shamila Yusuff, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 26, 2012
Role of computational methods in pharmaceutical sciencesSandhya Kortagere, Markus Lill, John Kerrigan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
The distribution of the cost of multiple sclerosis in the UK: how do costs vary by illness severity?David Tyas, John Kerrigan, Nicola Russell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2007
The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UKMichelle Orme, John Kerrigan, David Tyas, et al.
Oncotarget|February 6, 2016
MTHFD2--a new twist?Philip M Tedeschi, Kathleen W Scotto, John Kerrigan, et al.
Pharmacoeconomics|June 20, 2008
Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UKRay Gani, Gavin Giovannoni, David Bates, et al.
Biochemistry|December 5, 2008
Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activityHye-Jin Park, Haiyan Zheng, Diptee Kulkarni, et al.
The Journal of Biological Chemistry|August 11, 2011
Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIαRen-Kuo Lin, Nai Zhou, Yi Lisa Lyu, et al.
BMC Cancer|July 18, 2015
Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomasSunniva Stordal Bjørklund, Vessela N Kristensen, Michael Seiler, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analoguesLata T Gooljarsingh, Christine Fernandes, Kang Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate CancerNitu Bansal, Monica Bartucci, Shamila Yusuff, et al.
Pageof 2